Natural Killer Cells and Their Use for Cancer Immunotherapy
Welcome!
We are delighted that you have chosen to enhance your educational journey in immuno-safety science by enrolling in this module. The "Natural Killer Cells and Their Use for Cancer Immunotherapy" lecture is one in a series of ten lectures included in the Cancer Immunotherapies module and is led by Dr. Alexandre Iannello at Sonoma Biotherapeutics. Please review the learning objectives below for more information on what you will learn in this lecture.
If you are new to HESI and would like to learn more about our organization, please take a moment to visit our website at https://hesiglobal.org.
Target Audience
This course is intended to serve as a resource for those who are interested in learning about cancer immunotherapies and/or looking for professional development opportunities in the form of continuing education and networking.
Learning Objectives
The learner will:
- Understand the biology of Natural Killer (NK) cells
- Understand how Natural Killer cells recognize and eliminate tumor cells
- Understand the regulatory functions of Natural Killer cells
- Understand the different therapeutic strategies for NK-based cancer immunotherapy
Lectures in this module
Overview of Cancer Immunotherapies
Overview: Toxicity as a Result of Immunomodulation
Natural Killer Cells and Their Use for Cancer Immunotherapy
Cytokine Release Syndrome and "Cytokine Storms"
Other Toxicities Associated with Therapies Leveraging Adaptive Immunity
Assessing Risk of Adverse Pregnancy Outcomes for Immuno-Oncology Programs
Nonclinical Safety Assessment of Neoantigen-Targeting Therapies
Quantitative Systems Pharmacology/Toxicology for Immuno-oncology Therapies
Neurotoxicity across Cancer Immunotherapy Modalities
Regulatory Considerations for Cancer Immunotherapies: Preclinical Focus
Dr. Alexandre Iannello, PhD
Sonoma Biotherapeutics
Available Credit
- 1.00 Participation